Connect with us

MAM

Britannia appoints Varun Berry as COO, VP-marketing & Sales

Published

on

MUMBAI: Britannia Industries has announced key appointments in its management functions.

The company has appointed Varun Berry as COO and VP of marketing, sales and innovation.

He replaces Neeraj Chandra who has moved on to take over the role of VP of strategy and new business development.

Advertisement

Berry comes in with over 27 years of work experience with premier companies like Hindustan Unilever and Pepsico, both in India and overseas.

Britannia has also named Vinod Menon as the VP and CFO effective 1 February. Menon replaces Raju Thomas, who will relinquish his post on 31 January.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

MAM

Beacon Group appoints Dr Rajesh Patel as Group CEO

36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.

Published

on

MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.

In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.

The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.

Advertisement

Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.

For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.

Advertisement
Continue Reading

Advertisement News18
Advertisement
Advertisement Whtasapp
Advertisement Year Enders

Indian Television Dot Com Pvt Ltd

Signup for news and special offers!

Copyright © 2026 Indian Television Dot Com PVT LTD